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Porcine cirvorirus (PCV) is a non-cytophatogenic 
non-enveloped virus with icosahedral symmetry and 
a single-stranded circular DNA as genome1 that codes 
for the capsid protein (cap gene in ORF2) and repli-
case (rep gene in ORF1)2. Type 1 porcine circovirus 
(PCV1) is classically associated to permanent infec-
tions in PK-15 while type 2 (PCV2) might have a role 
on some diseases of the swine such as post-weaning 
multi-systemic wasting syndrome and reproductive 
failures3.
Currently, little is known on the genetic stability 
of PCV2 in vitro, mainly due to the tricky nature of 
PCV2 isolation in cell culture and the need for im-
mune reagents for the confirmation of virus isolation.
The aim of this investigation was to assess the ge-
netic divergence of PCV2 after low passage in VERO 
and SK-RST cell lines and to suggest the detection of 
evolutionary signal as a tool for the confirmation of 
virus isolation.
Two pools (12-04 and 17-04) of spleen/liver/ lymph 
nodes from two different adult swine collected at a 
slaughterhouse, previously positive for PCV24 were 
used for cell culture isolation. The pools were prepared 
as 20% suspensions (w/v) in TE buffer (10 mMTris– 
HCl, 1 mM EDTA, pH 8.0) and stored at -80 ºC.
The Cap gene of porcine circovirus type 2 (PCV2) evolves 
by positive selection in vitro
O gene Cap de circovírus suíno tipo 2 (PCV2) evolui por seleção positiva in vitro
Paulo Eduardo BRANDÃO1; Sibele Pinheiro de SOUZA1; Alessandra Marnie Martins Gomes de 
CASTRO1; Leonardo José RICHTZENHAIN1
1Department of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine,  
University of São Paulo, Brazil
Correspondence to: 
Paulo Eduardo Brandão 
Departamento de Medicina Veterinária Preventiva e Saúde Animal, 
Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo 
Av. Prof. Dr. Orlando Marques de Paiva, 87, Cidade Universitária, CEP 
05508-270,São Paulo, SP, Brazil 






This article reports the genetic divergence of PCV2 after passages in VERO and SK-RST cell lines. Fisher’s exact test 
indicated a trend for positive selection on the cap gene. These results allow insights on the development of PCV2 
vaccines and the evolution of the genus Circovirus.
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Resumo
Este artigo relata a divergência genética de PCV2 após passagens em células das linhagens VERO e SK-RST. O teste 
exato de Fisher indicou tendência para seleção positiva no gene cap. Estes resultados permitem inferências relativas ao 
desenvolvimento de vacinas contra PCV2 e sobre a evolução do gênero Circovirus.
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The two suspensions were filtered through 0.22 µm 
membranes (MilliporeTM) and a volume of 0.5 mL was 
inoculated in 24-hour-old 50% confluent monolayers 
of both VERO (green monkey kidney) and SK-RST 
(swine kidney) cells in 25 cm2 flasks. Minimum es-
sential medium (MEM) was used as negative control 
inoculum. After one hour at 37 ºC, the inocula were 
discarded, the monolayers were rinsed with 5 mL of 
MEM and next 7 mL of MEM plus 5% fetal bovine 
serum were added. Each passage was kept at 37 ºC for 
up to one week and observed daily under light mi-
croscope. For the second, third and forth passages of 
each sample in each of the two cell lines, the previous 
passage was frozen at -80 ºC and thawed at room tem-
perature and the same procedures described above 
were used. 
Each inoculated monolayer (n = 16) and the mock-
infected monolayers were monitored for the presence 
of PCV2 genomic DNA with a PCR targeted to the 
region between ORFS 1 and 2 as described by De Cas-
tro et al.4, with a 476-bp amplicon containing both 
Cap and Rep partial sequences. The 476-bp amplicons 
were purified from agarose gels with GFX kit (GE 
Healthcare) and submitted to bi-directional sequenc-
ing with BigDye 3.1 (Applied Byosystems) accord-
ing to manufacturer’s instructions and sequences were 
resolved in a ABI-377 automatic sequencer (Applied 
Byosystems).
Putative amino acid sequences were aligned using 
the BLOSUM62 matrix with CLUSTAL/W in Bioedit 
v. 5.0.95. Nucleotide and amino acid identities were 
calculated with Bioedit v. 5.0.9 and amino acid simi-
larities were calculated according to amino acids clas-
sification by Alnahi6.
Codon-based Fisher’s exact test was applied to se-
quences from each sample, cell line and partial gene, 
i. e., rep and cap, for the detection of positive selection 
(if p < 0.05) or, instead, purifying selection (if p = 1), 
using the software Mega 47.
After four serial passages in VERO and SK-RST 
cells, samples 12-04 and 17-04 produced no alteration 
in the monolayers and culture media and no cytho-
patic effect after seven days of incubation.
For the first passage of strain 17-04 compared to the 
second and third ones in VERO cells, nucleotide and 
amino acids identities for the Cap region were 99.3 
and 98.1% respectively (Table 1), with amino acid 
similarity of 100% as a result of a G197C polar-to-po-
lar amino acid substitution corresponding to a G589T 
nucleotide substitution.
Between the first and second passages of strain 12-
04 in VERO, polymorphism occurred at the Rep re-
gion, with nucleotide and amino acids identities of 
96.7 and 96.5%, respectively, (Table 1), with amino ac-
ids similarity of 96.50% resulted from a Q297P polar-
to-non-polar amino acids substitution due to A890C 
and G891C nucleotides substitutions at this region. 
Furthermore, a synonymous G876C nucleotide sub-
stitution was also detected.
No variation was detected (nucleotide identities = 
100%) neither at the Cap region for the first, second 
and third passages of strain 17-04 in SK-RST cells 
and first and second passages of strain 12-04 in both 
VERO and SK-RST nor at the Rep region of the first, 
Table 1 - Nucleotide (nt) and amino acids (aa) identities for the replicase (Rep) and capsid (Cap) 
regions of PCV2 for serial passages of samples 17-04 and 12-04 in VERO and SK-RST cells
Sample Cell line Passages Rep nt Rep aa Cap nt Cap aa
17-04 VERO 1st → 2nd 100% 100% 99.3% 98.1%
17-04 SK-RST 1st → 2nd and 3rd 100% 100% 100% 100%
12-04 VERO 1st → 2nd 96.7% 96.5% 100% 100%
12-04 SK-RST 1st → 2nd 100% 100% 100% 100%
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second and third passages of strain 17-04 in both cell 
lines and 12-04 in SK-RST (Table 1).
Passages 3 and 4 of samples 12-04 and 17-04 in SK-
RST and VERO and passage 4 of sample 17-04 in SK-
RST resulted in no amplification after PCR and thus 
no sequences are available for these. The nucleotide 
sequences generated were assigned GenBank acces-
sion numbers EU909392 to EU909400.
Regarding the Cap gene, one can notice nucleo-
tide and amino acids diversity amongst the first and 
the following passages as in the case of strain 17-04 
in VERO (Table 1), a suggestion that the nucleotide 
plesiomorphic states found in the original virus were 
under a substitution process due to selective pressure 
caused by the cell line used. 
As the capsid protein plays a major role in receptor 
binding8, the polymorphism in the primary structure 
of this protein as reported here might be interpreted 
as a result of the adaptation of the viral population to 
the membrane receptors of VERO cells.
Amino acids substitutions such as P110A and 
R191S in the capsid protein are molecular markers to 
in vitro PCV2 attenuation9. Nonetheless, amino acids 
substitutions at the replicase protein of PCV2 grown 
in vitro, as detected for strain 12-04 in VERO cells, 
have not been described so far.
Nonetheless, despite the suggestion of a cell-driven 
selection on these PCV2 strains, it must be consid-
ered that the polymorphisms described herein might 
have been originated not from selection, but genetic 
drift.
The only p value lower than 1 resulted from Fisher’s 
exact test was 0.772 for the capsid protein of strain 17-
04 in VERO cells (Table 2), leading to the conclusion 
that there was a trend for positive selection regarding 
this PCV -2 strain in VERO cells, while in SK-RT no 
PCV2 was isolated and the sequences retrieved might 
be a residue of the original sequence present in the 
inoculum.
PCV2 isolation has been achieved in a range of cell 
lines with variable success frequencies10,11, but the 
methods reported hitherto for the confirmation of 
virus isolation did not include evolutionary signal de-
tection as proposed herein.
The demonstration that, after low in vitro passage, 
PCV2 strains might not be genetically stable is of ma-
jor importance for the understanding for the develop-
ment of cell-culture-derived circovirus vaccines. 
Also, polymorphisms in the replicase protein of 
PCV2, a fact previously not reported, shall now on 
affect developments on the knowledge of evolutive 
trends in the genus Circovirus.
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Table 2 - Fisher’s exact test p values for passages of strains 17-04 and 12-
04 in VERO and SK-RST cells for capsid (Cap) and replicase 
(Rep) proteins of PCV2 
Strain Cell line Passages
P value
Cap Rep
17-04 VERO 1a → 2a 0.772 1.000
17-04 SK-RST 1a → 2a and 3a 1.000 1.000
12-04 VERO 1a → 2a 1.000 1.000
12-04 SK-RST 1a → 2a 1.000 1.000
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